ONYX PHARMACEUTICALS INC Other Cost and Expense, Operating
ONYX PHARMACEUTICALS INC reported Other Cost and Expense, Operating of $53.21 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherCostAndExpenseOperating · last filed 2012-08-06
- ONYX PHARMACEUTICALS INC other cost and expense, operating for the quarter ending 2012-06-30 was $53.21M, a 824.66% increase year-over-year.
- ONYX PHARMACEUTICALS INC other cost and expense, operating for the quarter ending 2012-03-31 was $3.18M, a 72.35% decline year-over-year.
- ONYX PHARMACEUTICALS INC other cost and expense, operating for the quarter ending 2011-12-31 was -$116.66M.
- ONYX PHARMACEUTICALS INC other cost and expense, operating for the quarter ending 2011-09-30 was $5.95M, a 5.75% increase year-over-year.
- ONYX PHARMACEUTICALS INC other cost and expense, operating for fiscal 2011 was -$93.47M, a 200.58% decline from fiscal 2010.
- ONYX PHARMACEUTICALS INC other cost and expense, operating for fiscal 2010 was $92.93M, a 5981.81% increase from fiscal 2009.
- ONYX PHARMACEUTICALS INC other cost and expense, operating for fiscal 2009 was $1.53M.
| Period end | Other Cost and Expense, Operating 3 month | Other Cost and Expense, Operating 6 month | Other Cost and Expense, Operating 9 month | Other Cost and Expense, Operating 12 month |
|---|---|---|---|---|
| 2012-06-30 | $53.21M 10-Q · filed 2012-08-06 | $56.39M 10-Q · filed 2012-08-06 | -$60.27M derived: sum of 3 quarters · filed 2012-08-06 | -$54.33M derived: sum of 4 quarters · filed 2012-08-06 |
| 2012-03-31 | $3.18M 10-Q · filed 2012-05-04 | -$113.48M derived: sum of 2 quarters · filed 2012-05-04 | -$107.54M derived: sum of 3 quarters · filed 2012-05-04 | -$101.78M derived: sum of 4 quarters · filed 2012-08-06 |
| 2011-12-31 | -$116.66M 10-K · filed 2012-02-27 | -$110.72M derived: sum of 2 quarters · filed 2012-02-27 | -$104.96M derived: sum of 3 quarters · filed 2012-08-06 | -$93.47M 10-K · filed 2012-02-27 |
| 2011-09-30 | $5.95M 10-K · filed 2012-02-27 | $11.70M derived: sum of 2 quarters · filed 2012-08-06 | $23.20M 10-Q · filed 2011-11-03 | $15.02M derived: sum of 4 quarters · filed 2012-08-06 |
| 2011-06-30 | $5.75M 10-Q · filed 2012-08-06 | $17.25M 10-Q · filed 2012-08-06 | $9.07M derived: sum of 3 quarters · filed 2012-08-06 | $14.70M derived: sum of 4 quarters · filed 2012-08-06 |
| 2011-03-31 | $11.49M 10-Q · filed 2012-05-04 | $3.32M derived: sum of 2 quarters · filed 2012-05-04 | $8.94M derived: sum of 3 quarters · filed 2012-05-04 | $100.98M derived: sum of 4 quarters · filed 2012-05-04 |
| 2010-12-31 | -$8.18M 10-K · filed 2012-02-27 | -$2.56M derived: sum of 2 quarters · filed 2012-02-27 | $89.48M derived: sum of 3 quarters · filed 2012-02-27 | $92.93M 10-K · filed 2012-02-27 |
| 2010-09-30 | $5.62M 10-K · filed 2012-02-27 | $97.66M derived: sum of 2 quarters · filed 2012-02-27 | $101.11M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $92.04M 10-K · filed 2012-02-27 | $95.48M derived: sum of 2 quarters · filed 2012-02-27 | ||
| 2010-03-31 | $3.45M 10-K · filed 2012-02-27 | |||
| 2009-12-31 | $1.53M 10-K · filed 2012-02-27 |